MBX Bio (MBX) - Net earnings per share growth forecast for next year

MBX Biosciences (MBX) - corporate logo

MBX Biosciences Inc (MBX) relies on peptide innovations to combat endocrine pathologies. The current consensus EPS growth forecast for next year demonstrates a recovery trend, where the status is -23.20. Geopolitical risks are constraining steady demand for drugs, while strict inventory management of active substances minimizes supply chain disruptions during research.

MBX Biosciences, Inc. (MBX): Net earnings per share growth forecast for next year from 09/14/2024 to 11/15/2026

MBX (MBX Biosciences, Inc.): analytical breakdowns and indicator data

- share price and consensus valuation forecast:
Comprehensive company analysis:MBX, mbxbio.com
Core merchandise of MBX Biosciences

For MBX Biosciences Inc (MBX), which develops unique peptide drugs for metabolic pathologies, the projected EPS dynamics for the coming year serve as a key valuation indicator. This metric aggregates current analyst forecasts regarding the growth rate of net income per share. The calculation is based on expected revenue growth relative to the base period. A decline in this figure signals that the market is revising the issuer's pricing power potential and suggests risks of a price correction.

Analysis of competing companies

ASND (Ascendis) - Earnings growth forecast for next year|Earnings growth forecast for next year Madrigal Pharmaceuticals|Earnings growth forecast for next year CORT|Net earnings per share growth forecast for next year RYTM (Rhythm Pharma)|Net earnings per share growth forecast for next year akerotx.com AKRO|Metsera Therapeutics (MTSR) - Expected net earnings per share growth next year|MLTX - Net earnings per share growth forecast for next year|CRNX: Net earnings per share growth forecast for next year|NAMS: Earnings growth forecast for next year|SLNO - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Amicus Corp|89bio Pharma (ETNB) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year agios.com (AGIO)|Expected earnings per share growth for next year structuretx.com GPCR|Net earnings per share growth forecast for next year MiMedx Group Inc MDXG|Expected earnings per share trend next year RZLT|lexpharma.com - Earnings growth forecast for next year|Altimmune Corp - Projected earnings per share increase next year|Aardvark Therapeutics Inc (AARD) - Net earnings per share growth forecast for next year|Net earnings per one share growth forecast for next year Sagimet Biosciences SGMT|BIOA (bioagelabs.com) - Earnings growth forecast for next year|Expected earnings per share growth for next year Biomea Fusion (BMEA)|Earnings growth forecast for next year QNCX|Projected earnings per share increase next year GUTS|Earnings growth forecast for next year VTVT (vTv Therapeutics Inc.)|Expected earnings per share trend next year ATPC|Pluristem Therapeutics - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year synlogictx.com SYBX|LPCN: Earnings growth forecast for next year|Matinas BioPharma Holdings, Inc. - Expected earnings per share trend next year|SPRB (Spruce Biosciences Inc.) - Earnings growth forecast for next year|galecto.com (GLTO) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Carmell Therapeutics (CTCX)|LUMO (Lumos Pharma Inc) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year organovo.com ONVO|Radius Health (RDUS) - Expected net earnings per share growth next year